This list is based on the watchlists of people on Stock Events who follow CDIO.BOATS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Show more...
FAQ
What is Cardio Diagnostics stock price today?▼
The current price of CDIO.BOATS is $1.94 USD — it has increased by +11.49% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardio Diagnostics stocks are traded under the ticker CDIO.BOATS.
What is Cardio Diagnostics market cap?▼
Today Cardio Diagnostics has the market capitalization of 3.54M
When is the next Cardio Diagnostics earnings date?▼
Cardio Diagnostics is going to release the next earnings report on June 03, 2026.
What is Cardio Diagnostics revenue for the last year?▼
Cardio Diagnostics revenue for the last year amounts to 70,000 USD.
What is Cardio Diagnostics net income for the last year?▼
CDIO.BOATS net income for the last year is -16.77M USD.
When did Cardio Diagnostics complete a stock split?▼
Cardio Diagnostics has not had any recent stock splits.